Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Director's Dealing

9 Jan 2026 15:19

RNS Number : 3922O
Seed Innovations Limited
09 January 2026
Β 

Β 

Β 

Β 

FOR IMMEDIATE RELEASE

Β 

9 January 2026

Β 

SEED Innovations Limited

("SEED" or the "Company")

Β 

Director's Dealing

Β 

SEED Innovations Limited ("SEED" or the "Company"), an AIM-quoted investing company, announces that that it was notified onΒ 9 January 2026Β thatΒ Galloway Limited, an entity indirectly wholly owned by Jim Mellon, Non-executive Chair of the Company, purchased a total of 1,193,261 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 2.92 pence per Ordinary Share on 8 January 2026.

Β 

As a result,Β Jim Mellon'sΒ total beneficial interest in the Company, including all entities closely associated, is now at 43,915,169 Ordinary Shares, representing 23.36% per cent of the total voting rights of the Company.

Β 

The notification below, made in accordance with the requirements of theΒ UKΒ Market Abuse Regulation, provides further detail.

Β 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Β 

1.

Β 

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Jim Mellon

Β 

Β 

Β 

Β 

2.

Β 

Reason for the notification

Β 

a)

Position/status

Chair

Β 

b)

Initial notification/Amendment

Initial Notification

Β 

Β 

Β 

Β 

3.

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

SEED Innovations Limited

Β 

b)

LEI

213800KV6ETTB1BRZ435

Β 

Β 

Β 

Β 

4.

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Description of the financial instrument, type of instrument

Ordinary Shares of no par value

Β 

b)

Identification code

GG00BRK9BQ81

Β 

c)

Nature of the transaction

Acquisition of 1,193,261 Ordinary Shares

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Β 

For further information please visit:β€―www.seedinnovations.co or contact:

Β 

Β 

SEED Innovations Limited

Beaumont

Cornish Limited

Shard Capital Partners LLP

St Brides Partners Limited

The Company

Nomad

Broker

Public Relations

Lance de Jersey

Roland Cornish

James Biddle

Isabella Pierre

Damon Heath

Ana Ribeiro

Isabel de Salis

info@seedinnovations.comβ€―

+44 (0) 207 628 3396

+44 (0)20 7186 9927

seed@stbridespartners.co.uk

Β 

NOTESΒ 

Β 

SEED Innovations Ltd (SEED.L)

SEED is an AIM-quoted investment company focused on providing access to high-growth robotics and AI ventures typically beyond the reach of everyday investors. The Company also oversees a legacy portfolio in wellness and life sciences, with a medium-term strategy to unlock its full value. Back by an experienced team and strong cash reserves, the Company remains agile and well-positioned to capitalise on new investment opportunities as they arise.

Β 

Nominated Adviser

Beaumont Cornish LimitedΒ ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to theΒ London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

Β 

Β 

TR1

Β 

Β 

Please note that from 22 March 2021, the Standard TR-1 Form should be completed and submitted to the FCA via our Electronic Submission System (ESS) in relation to notifications of voting rights held in issuers whose shares are admitted to trading on UK regulated markets.

Β 

Holders of voting rights in issuers whose shares are admitted to trading on UK prescribed markets such as AIM market, can continue to use this form to send their notifications to those issuers. Alternatively, if they wish they can register on ESS to be able to notify to us, produce a TR-1 Form via ESS and submit the downloaded version to issuers with shares admitted to trading on prescribed markets.

Β 

More information on how to submit a TR-1 Form via ESS is available here

Β 

Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

SEED Innovations Limited

1b. Please indicate if the issuer is a non-UK issuerΒ  (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Jim Mellon

City and country of registered office (if applicable)

c/o Viking House, Nelson Street, Douglas, Isle of Man IM1 2AH

4. Full name of shareholder(s) (if different from 3.) v

Name

Galloway Limited

City and country of registered office (if applicable)

Road Town, Tortola, British Virgin Islands

5. Date on which the threshold was crossed or reached vi:

8 January 2026

6. Date on which issuer notified (DD/MM/YYYY):

09/01/2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

23.36%

0.00%

23.36%

43,915,169

Position of previous notification (if

applicable)

22.20%

0.00%

22.20%

41,721,908

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

Β (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GG00BRK9BQ81

23,782,115

20,133,054

12.65%

10.71%

SUBTOTAL 8. A

43,915,169

23.36%

Β 

Β 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

Β 

SUBTOTAL 8.B.2

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Jim Mellon

12.65%

12.65%

Galloway Limited

10.71%

10.71%

Β 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

Β 

Place of completion

Douglas, Isle of Man

Date of completion

9 January 2026

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEASFNEFDKEFA
Date   Source Headline
27th Apr 202312:35 pmRNSInvestee Company Update: Little Green Pharma Ltd
24th Apr 20237:00 amRNSPortfolio Update: Northern Leaf CLN conversion
20th Apr 202310:01 amRNSSale of South West Brands to OTO for £6.2 million
17th Apr 202311:19 amRNSInvestee Company Update: Little Green Pharma LTD
11th Apr 20237:00 amRNSLeap Gaming Update – Offer Declared Unconditional
24th Mar 202311:04 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:26 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:25 amRNSInvestee Company Update: Little Green Pharma Ltd
15th Mar 202312:45 pmRNSAvextra AG Successfully Raises EUR 17 million
21st Feb 20237:00 amRNSPortfolio Company Update: South West Brands
15th Feb 202310:45 amRNSInvestee Company Update: Little Green Pharma Ltd
13th Feb 20233:00 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th Feb 20237:15 amRNSInvestee Company Update: Avextra
6th Feb 20232:45 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20232:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Jan 20232:15 pmRNSDirector Share Purchase
15th Dec 20224:22 pmRNSDirector Share Purchase
14th Dec 20224:07 pmRNSDirector Share Purchases
12th Dec 20225:22 pmRNSInterim Results
7th Dec 20227:00 amRNSEUR14 million Offer for Leap Gaming
5th Dec 20227:00 amRNSInvestee Company Update: Clean Food Group Ltd
2nd Dec 202210:00 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Dec 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
11th Nov 202210:15 amRNSPortfolio Company Update: South West Brands
2nd Nov 20221:20 pmRNSInvestee Company Update: Little Green Pharma
4th Oct 202212:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Oct 20227:30 amRNSInvestee Company Update: Avextra
16th Sep 20229:03 amRNSEurox – Change of Name to Avextra
7th Sep 20224:00 pmRNSResult of AGM & Updated Investor Presentation
2nd Sep 20222:50 pmRNSPortfolio Valuation Update & Investor Presentation
9th Aug 20227:00 amRNSNotice of AGM & Investor Presentation
8th Aug 20227:00 amRNSFurther Investment in South West Brands Limited
1st Aug 20227:00 amRNSNew Investment: Clean Food Group Ltd
21st Jul 20227:00 amRNSFinal Results
12th Jul 202212:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
1st Jul 20225:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Jun 20223:05 pmRNSLoan to Portfolio Company, Leap Gaming
25th May 20222:08 pmRNSInvestee Company Update: Yooma Wellness Inc.
24th May 20227:00 amRNSInvestee Company Update: Leap Gaming
19th May 20227:00 amRNSInvestee Company Update - Little Green Pharma
18th May 20224:20 pmRNSInvestee Company Update: Yooma Wellness Inc.
4th May 20224:01 pmRNSInvestee Company Update: Yooma Wellness Inc.
3rd May 20227:00 amRNSInvestee Company Update - Little Green Pharma
19th Apr 20221:00 pmRNSInvestee Company Update: Little Green Pharma
6th Apr 20227:00 amRNSInvestee Company Update: Eurox Group
5th Apr 20227:00 amRNSFood Standard Agency’s Public List of CBD Products
31st Mar 202211:16 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Mar 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
18th Feb 20229:41 amRNSInvestee Company Update: Little Green Pharma Ltd
8th Feb 20221:51 pmRNSInvestee Company Update: Little Green Pharma Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.